Penumbra introduced the Indigo™ System CAT™ RX for the removal of fresh, soft emboli and thrombi from the coronary and peripheral vasculature. Engineered with neuro-tracking technology, CAT RX is designed to navigate tortuous anatomy and track to distal coronary vasculature while maintaining sustained mechanical aspiration with the Penumbra ENGINE™.
The latest CHEETAH Study was a prospective, multicenter study evaluating the safety and performance of CAT RX1 in patients with a high thrombus burden acute coronary vessel occlusion prior to PCI. CHEETAH met its primary endpoint while demonstrating high technical success and safety with improved TIMI flow, myocardial perfusion and no device-related SAEs (including stroke). Learn more about the CHEETAH study results here: CHEETAH Study Results
1. Precaution: The safety and effectiveness of this device for use in the treatment of ST-Elevation Myocardial Infarction (STEMI) has not been established. Complications from the use of this device in this manner could lead to death, permanent impairment, and/or the need for emergency medical intervention.